Smith-Lemli-Opitz Syndrome (SLOS): Cholesterol Biosynthesis Defects and Posture Rehabilitation
In short
Physiotherapy for Smith-Lemli-Opitz syndrome integrates oral cholesterol replacement, sensory integration for extreme photosensitivity, and core hypotonia management.
In this guide (4 sections)
DHCR7 Deficiency, 7-Dehydrocholesterol Toxicity, and Hedgehog Signaling
Smith-Lemli-Opitz Syndrome (SLOS) is an autosomal recessive inborn error of cholesterol biosynthesis with an estimated carrier frequency of 1 in 30 in individuals of European descent, manifesting clinically in 1 in 20,000 to 60,000 live births. It is caused by biallelic loss-of-function mutations in the DHCR7 gene on chromosome 11q13.4, encoding the terminal enzyme 7-dehydrocholesterol reductase. This enzyme normally catalyzes the reduction of 7-dehydrocholesterol (7-DHC) to cholesterol. In its absence, plasma and tissue cholesterol levels plummet, while toxic 7-DHC and 8-dehydrocholesterol precursors accumulate systemically.
The pathogenesis operates through two devastating mechanisms: cellular membrane lipid raft disruption impairing neurotransmitter receptor trafficking, and failure of covalent cholesterylation of the Sonic Hedgehog (Shh) morphogen. Shh signaling is essential for ventral neural tube patterning, craniofacial morphogenesis, and limb bud patterning. Clinically, infants present with microcephaly, distinctive facial dysmorphisms (anteverted nares, ptosis, micrognathia), cleft palate, postaxial polydactyly, pathognomonic Y-shaped cutaneous 2-3 toe syndactyly, extreme photosensitivity, severe sensory aversion, and profound generalized hypotonia with delayed motor milestones.
Standardized Clinical Outcome Measures and Phenotypic Staging
| Clinical Phenotypic Marker | Standard Diagnostic Evaluation | Phenotypic Finding in SLOS | Rehabilitation & Environmental Strategy | |
|---|---|---|---|---|
| 2-3 Toe Cutaneous Syndactyly | Visual podiatry examination of both feet | Y-shaped soft tissue webbing connecting 2nd and 3rd toes (> 95% of cases) | Does not impede foot biomechanics; standard orthotics fit comfortably | |
| Plasma 7-DHC / Cholesterol Ratio | Gas chromatography-mass spectrometry (GC-MS) | Markedly elevated 7-dehydrocholesterol; low plasma cholesterol | Therapy must be scheduled around oral cholesterol supplement feeds | |
| Extreme Cutaneous Photosensitivity | Inspection of skin exposed to ambient sunlight / UVA | Severe erythema, burns, and irritability from minimal UV light | Therapy conducted in UV-filtered, window-blinded indoor sensory rooms | |
| Gross Motor Milestone Staging | Peabody Motor Scales (PDMS-2) / Alberta Infant Motor Scale | Severe motor delays; unassisted walking achieved in mild-moderate cases | Supported seating, therapy ball balance facilitation, dynamic standing frames | |
| Sensory Hyperarousal / Sleep Disturbance | Sensory Profile 2 / overnight sleep actigraphy | Severe tactile defensiveness, auditory hyperreactivity, sleep inversion | Calming proprioceptive deep pressure, rhythmic swinging, low lighting |
Standardized Clinical Rehabilitation Protocols and Metabolic Coordination
- Coordination with Oral Cholesterol Supplementation: Coordinate motor therapy sessions with the patient's nutritional schedule; oral crystalline cholesterol and bile acid supplementation progressively restores cell membrane fluidity and muscle tone; therapy yields the highest motor learning gains when metabolic nutrition is optimized.
- UV-Filtered Therapy Environments and Photoprotection: Conduct physiotherapy strictly indoors with blackout curtains and UV-filtered LED lighting; high 7-DHC levels in the skin react violently with ultraviolet light, causing severe phototoxic burns and intense skin pain that completely halts motor participation.
- Core Muscular Activation and Postural Balance Training: Prescribe prone horizontal play over foam wedges, therapy ball bouncing, and dynamic tilt-board balance challenges; counteracting severe baseline hypotonia improves core spinal stability, allowing the child to achieve independent sitting and transition to supported walkers.
Frequently Asked Questions
Why is oral cholesterol prescribed as a medicine in Smith-Lemli-Opitz syndrome?
In SLOS, the body lacks the final chemical tool needed to make cholesterol. While adults often hear about cholesterol as something to avoid, growing children desperately need cholesterol to build cell walls, nerve insulation, and brain hormones. Drinking cholesterol medicine provides the essential building blocks their body cannot produce.
What is the 2-3 toe webbing seen in almost all SLOS children?
Nearly all children with SLOS are born with soft skin webbing connecting their second and third toes together (syndactyly). It looks like a little Y-shape between the toes. It is completely harmless, painless, and does not interfere with learning to walk or wearing shoes.
Why do therapy rooms need special lighting for a child with SLOS?
The chemical that builds up in their blood (7-dehydrocholesterol) makes their skin intensely sensitive to ultraviolet rays from the sun and bright fluorescent lights. Direct sunlight can cause severe skin burns in just a few minutes, so therapists use dimmed, UV-safe indoor lights to keep them comfortable.
Related condition guides
Related recovery guides & articles
BookPhysio.in Editorial Team
The BookPhysio.in editorial team writes and maintains this content, checking it against reliable clinical sources. Content follows our medical review policy: general information only, and no page claims a clinical review until a named registered physiotherapist has signed it off.
Read our medical review policy